During the past decade, Hämato-Onkologie im Medicum/Home conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hämato-Onkologie im Medicum/Home" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hämato-Onkologie im Medicum/Home" are "Breast Cancer" (1 trials) and "Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Hämato-Onkologie im Medicum/Home" in a lesser frequency.

Most popular intervention types in "Hämato-Onkologie im Medicum/Home" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (2 trials), "Paclitaxel" (2 trials), "5-Fluorouracil" (1 trials), "Atezolizumab" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hämato-Onkologie im Medicum/Home" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hämato-Onkologie im Medicum/Home". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hämato-Onkologie im Medicum/Home, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hämato-Onkologie im Medicum/Home, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".